Bookmark

Add to MyYahoo RSS

ImmunoGen News

News on ImmunoGen (Ticker: IMGN) continually updated from thousands of sources around the net.

Wednesday Jun 25 | The Washington Post

U.S. Stock-Index Futures Little Changed Before Data as IMS Gains

U.S. stock-index futures were little changed, after equities slipped for a second day yesterday, as violence in the Middle East increased, and investors awaited data on durable-goods orders in the world's largest economy.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Stanley, Investment Banking, Morgan Stanley European Fund, Financial Services, Morgan Stanley, Science / Technology

Mon Jun 16, 2014

Business Wire

Press release distribution, EDGAR filing, XBRL, regulatory filings

The corrected release reads: IMMUNOGEN, INC. ANNOUNCES PRECLINICAL FINDINGS FOR IMGN779, A POTENTIAL... )--The International Association of Machinists and Aerospace Workers today announced it reached tentative agreements with US Airways on contracts covering approximat... )--Re: United Utilities Water Plc GBP 100,000,000.00 MATURING: 12-Jul-2057 ... (more)

Comment?

Related Topix: Chipotle Mexican Grill, Restaurant Management, Biotech, Medicine, Healthcare Industry

Hispanic Business

ImmunoGen, Inc. Announces Preclinical Findings for IMGN779, a...

The data were presented at the 19th . IMGN779 is a novel, CD33-targeting, DNA-alkylating ADC that is a potential treatment for acute myeloid leukemia .

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, ImmunoGen

Sat Jun 14, 2014

Boston.com

Game changers ImmunoGen's breast cancer therapy took time

Patients and doctors applauded last year when the powerful new breast cancer therapy Kadcyla made its market debut, following a long and winding journey to approval for what many view as a miracle medicine.

Comment?

Related Topix: Biotech, Medicine, ImmunoGen, Healthcare Industry

Thu Jun 12, 2014

AmericanBankingNews.com

Immunogen Receives Consensus Rating of "Buy" from Brokerages

Immunogen has earned an average rating of "Buy" from the thirteen brokerages that are presently covering the stock, Analyst Ratings News reports .

Comment?

Related Topix: Biotech, Medicine, ImmunoGen, Healthcare Industry

TheStreet.com

Will This Analyst Upgrade Help Immunogen (IMGN) Stock Today?

Your browser is not supported. Please upgrade to one of the following browsers: Google Chrome Mozilla Firefox Apple Safari Microsoft Internet Explorer 8+ You may proceed to the site by clicking here , however some pages might not work correctly.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Mozilla, TheStreet

•••
•••
•••
•••
•••

Ashburn Jobs

•••
•••
•••
•••